The neurobiology of isoprostanes and Alzheimer's disease

被引:52
作者
Pratico, Domenico [1 ]
机构
[1] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2010年 / 1801卷 / 08期
关键词
Isoprostane; Oxidative stress; Alzheimer's disease; Amyloid beta; Thromboxane receptor; APOLIPOPROTEIN-E-DEFICIENT; REDUCES OXIDATIVE DAMAGE; LIPID-PEROXIDATION; THROMBOXANE RECEPTOR; AMYLOID PATHOLOGY; BRAIN; STRESS; F-2-ISOPROSTANES; MODEL; ACTIVATION;
D O I
10.1016/j.bbalip.2010.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In its sporadic form Alzheimer's disease (AD) results from a combination of genetic and environmental risk factors with abnormal oxidative reactions, which result in free radical mediated injury of the brain. Isoprostanes are oxidized lipids formed by a free radical mediated mechanism, which in recent years have emerged as a reliable and sensitive marker of lipid peroxidation and oxidative stress. Consistent data show that they are increased in the brain of human AD as well as AD animal models. Besides their role as biomarkers, isoprostanes possess important biological effects, functioning as mediators of the cellular response to oxidative stress within the CNS. Recent evidence indicates that these lipid oxidation products, by activating the thromboxane receptor system, mediate the pro-amyloidotic neuronal response to oxidative stress in an experimental model of AD. This novel observation has important clinical implication, since pharmacologic modulation of the TP receptor system by selective antagonists, some of which are already available, could represent a novel therapeutic opportunity for AD as disease-modifying agents. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:930 / 933
页数:4
相关论文
共 37 条
[11]   Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease [J].
Liang, XB ;
Wang, Q ;
Hand, T ;
Wu, LJ ;
Breyer, RM ;
Montine, TJ ;
Andreasson, K .
JOURNAL OF NEUROSCIENCE, 2005, 25 (44) :10180-10187
[12]   The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse [J].
Lim, GP ;
Chu, T ;
Yang, FS ;
Beech, W ;
Frautschy, SA ;
Cole, GM .
JOURNAL OF NEUROSCIENCE, 2001, 21 (21) :8370-8377
[13]   Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment [J].
Markesbery, WR ;
Kryscio, RJ ;
Lovell, MA ;
Morrow, JD .
ANNALS OF NEUROLOGY, 2005, 58 (05) :730-735
[14]   Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease [J].
Montine, TJ ;
Markesbery, WR ;
Morrow, JD ;
Roberts, LJ .
ANNALS OF NEUROLOGY, 1998, 44 (03) :410-413
[15]  
Montine TJ, 2001, ARCH PATHOL LAB MED, V125, P510
[16]   Increased CSF F2-isoprostane concentration in probable AD [J].
Montine, TJ ;
Beal, MF ;
Cudkowicz, ME ;
O'Donnell, H ;
Margolin, RA ;
McFarland, L ;
Bachrach, AF ;
Zackert, WE ;
Roberts, LJ ;
Morrow, JD .
NEUROLOGY, 1999, 52 (03) :562-565
[17]   Opposite effects of anandamide and n-arachidonoyl dopamine in the regulation of prostaglandin E2 and 8-iso-PGF2α formation in primary glial cells [J].
Navarrete, Carmen M. ;
Fiebich, Bernd L. ;
Garcia de Vinuesa, Amaya ;
Hess, Sandra ;
de Oliveira, Antonio C. P. ;
Candelario-Jalil, Eduardo ;
Caballero, Francisco J. ;
Calzado, Marco A. ;
Munoz, Eduardo .
JOURNAL OF NEUROCHEMISTRY, 2009, 109 (02) :452-464
[18]   Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice [J].
Praticó, D ;
Uryu, K ;
Sung, S ;
Tang, S ;
Trojanowski, JQ ;
Lee, VMY .
FASEB JOURNAL, 2002, 16 (07) :1138-+
[19]   F2-isoprostanes:: sensitive and specific non-invasive indices of lipid peroxidation in vivo [J].
Praticò, D .
ATHEROSCLEROSIS, 1999, 147 (01) :1-10
[20]  
Praticò D, 2004, J ALZHEIMERS DIS, V6, P171